PMID: 7539701Mar 1, 1995Paper

A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
M B WilwerdingL M Athmann

Abstract

Sedation may be a dose-limiting side-effect of opioid therapy in some cancer patients. This study was designed to evaluate further the use of the psychostimulant, methylphenidate, an agent that has been reported to counter-act opioid-induced sedation, in patients with cancer-related pain. Patients receiving a stable dose of an opioid for cancer-related pain were recruited for this randomized, double-blind, crossover clinical trial. In addition to their regular dose of narcotics, they received 5 days of methylphenidate followed by 5 days of placebo, or vice versa. Our data did not definitively demonstrate any statistically significant benefit for methylphenidate, but did suggest that this drug could mildly decrease narcotic-induced drowsiness and could increase night-time sleep. These data, in conjunction with other published data, suggest that methylphenidate can counteract narcotic-induced daytime sedation to a limited degree.

References

Jul 11, 1985·The New England Journal of Medicine·K M Foley
Sep 10, 1984·The American Journal of Medicine·C E Inturrisi
Dec 1, 1980·British Journal of Anaesthesia·M E Dodson, J M Fryer
Nov 1, 1982·Cancer·R L Daut, C S Cleeland

❮ Previous
Next ❯

Citations

Nov 1, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Helen G Mar FanIan F Tannock
Mar 1, 2005·Journal of Pain and Symptom Management·Richard Benoit Francoeur
Jun 19, 2001·Primary Care·J L Abrahm, L Snyder
May 23, 2001·Journal of Pain and Symptom Management·N E SlatkinT M Bolton
Nov 6, 1998·Journal of Pain and Symptom Management·S Dalal, R Melzack
Jul 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S Ahmedzai
Oct 17, 2006·Journal of Palliative Medicine·Heike Reineke-BrackeFrank Elsner
Sep 12, 2009·The American Journal of Hospice & Palliative Care·Wael LasheenDilara Seyidova Khoshknabi
Jul 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amanda R MoraskaCharles L Loprinzi
Jan 1, 2009·Indian Journal of Palliative Care·Vijayakumar Narayanan, Cherian Koshy
Jun 8, 2014·Journal of Analytical Toxicology·Joy Y JiangJoseph D Ma
Sep 11, 2013·Journal of Pain and Symptom Management·Katrin Ruth SigurdardottirDagny Faksvåg Haugen
Jan 22, 2011·Journal of Pain and Symptom Management·Ollie MintonPatrick C Stone
Nov 16, 2010·Journal of Pain and Symptom Management·Paul HowardAndrew Wilcock
Jul 23, 2003·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Lynn WebsterGregory Stoddard
Jul 25, 2000·Mayo Clinic Proceedings·T D Challman, J J Lipsky
Mar 4, 2006·Clinical Lung Cancer·Jennifer S TemelThomas J Lynch
Oct 16, 2007·Pediatric Clinics of North America·Leslie S Kersun, Eyal Shemesh
May 29, 2007·Journal of Pain and Symptom Management·Naoki Matsuo, Tatsuya Morita
Apr 28, 2000·Clinics in Geriatric Medicine·J L Abrahm
Aug 1, 2002·BMC Palliative Care·Frank D FerrisLinda L Emanuel
Jun 22, 2014·Neuropharmacology·Eugenia Sinita, David Coghill
Apr 28, 2004·Clinical Journal of Oncology Nursing·Patricia Beach
Dec 31, 2005·Clinical Journal of Oncology Nursing·Laura BourdeanuMarjorie Funk
Nov 17, 2001·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·S Young-McCaughan, C Miaskowski
Jan 12, 2000·The Annals of Pharmacotherapy·P J CoreyR A Weathermon
Sep 19, 1998·Psycho-oncology·E Bruera, C M Neumann
Jan 25, 2008·Palliative Medicine·Lukas RadbruchUNKNOWN Research Steering Committee of the European Association for Palliative Care (EAPC)
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark RozansMarc J Kahn
Nov 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dominik R BertholdIan F Tannock
Mar 10, 2005·The Annals of Pharmacotherapy·James E Reissig, Amy M Rybarczyk
May 7, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathryn J RuddyCharles L Loprinzi
Jan 22, 2014·The Cancer Journal·Debra Barton
Jul 17, 2009·Palliative Medicine·J NiklesD Currow
Dec 7, 2011·The American Journal of Hospice & Palliative Care·Eric Prommer
Apr 2, 2003·International Journal of Palliative Nursing·Syed Q Abbas, Zafar Abbas
Feb 3, 2006·The American Journal of Hospice & Palliative Care·Amit SoodCharles L Loprinzi
Dec 5, 2018·Palliative & Supportive Care·Sriram YennurajalingamEduardo Bruera
Jul 9, 2004·British Journal of Cancer·L I Wagner, D Cella
Oct 25, 2013·Current Opinion in Supportive and Palliative Care·Tobias SteiglederChristoph Ostgathe
Feb 6, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lesley A HensonIrene J Higginson
May 31, 2015·The Cochrane Database of Systematic Reviews·Martin MückeLukas Radbruch
Mar 28, 2017·Pain and Therapy·Joseph V PergolizziRobert B Raffa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.